Clinical Trial Update: Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pharmacologic augmentation of targeted cognitive training in schizophrenia and schizoaffective disorder has completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: University of California, San Diego | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-12-17